Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty
1 other identifier
interventional
230
1 country
1
Brief Summary
The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing or portable negative pressure wound dressing is superior in preventing wound complications and infection rates in obese patients undergoing total joint arthroplasty (TJA). Approximately 240 subjects (120 for total knee arthroplasty and 120 for total hip arthroplasty) will be enrolled to evaluate the outcomes associated with silver impregnated dressings and negative pressure wound therapy (NPWT) in treating this subset of patients and analyze the cost benefit of each.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Nov 2017
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2017
CompletedFirst Submitted
Initial submission to the registry
November 14, 2017
CompletedFirst Posted
Study publicly available on registry
November 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedResults Posted
Study results publicly available
April 22, 2022
CompletedApril 22, 2022
March 1, 2022
3.4 years
November 14, 2017
March 29, 2022
March 29, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Visual Analog Scale (VAS) Pain Score
A patient is asked to indicate his/her perceived scar severity along a 100 mm horizontal line, and this rating is then measured from the left edge (=VAS score). The total score range is 0 (worst possible scar) to 100 (best possible scar); the higher the score, the better the scarring.
Day 8
Wound Evaluation Scale (WES)
WES is a 6-item scale. Items 1-5 are scored 0 (yes) or 1 (no), and item 6 is scored 0 (poor) or 1 (acceptable). The total score range is 0-6; the higher the score, the more optimal the wound healing.
Day 8
Study Arms (2)
Antimicrobial Barrier Dressing
ACTIVE COMPARATORpostoperative wound dressing with either anti-microbial dressing placed in the operating room from surgery to postoperative day 7
Closed-incision Negative Pressure Therapy
ACTIVE COMPARATORportable NPWT device placed in the operating room from surgery to postoperative day 7
Interventions
Ionic Silver is a soft, nonwoven pad or ribbon that features the gelling benefits of Hydrofiber technology plus antimicrobial ionic silver.
PICO provides suction known as negative Pressure wound Therapy (NPWT) which draws out excess fluid from a wound and protects the injured area from getting dirty to ultimately help promote healing. PICO consists of an nPwT pump connected to an absorbent gentle adhesive dressing
Eligibility Criteria
You may qualify if:
- Those identified at pre-operative testing to have an elevated BMI (\> 35)
You may not qualify if:
- Active infection
- previous scar or wound healing complication
- post traumatic degenerative joint disease (DJD) with hardware
- revision surgery
- inflammatory arthritis
- anticoagulation outside of the standard of care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ran Schwarzkopf MD MSc
- Organization
- NYU Langone Health
Study Officials
- PRINCIPAL INVESTIGATOR
Ran Schwarzkopf, MD
NYU Langone Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2017
First Posted
November 17, 2017
Study Start
November 13, 2017
Primary Completion
April 1, 2021
Study Completion
June 1, 2021
Last Updated
April 22, 2022
Results First Posted
April 22, 2022
Record last verified: 2022-03